2010
DOI: 10.1016/j.canlet.2010.01.024
|View full text |Cite
|
Sign up to set email alerts
|

Potentiation of etoposide-induced apoptosis in HeLa cells by co-treatment with KG-135, a quality-controlled standardized ginsenoside formulation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2011
2011
2017
2017

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 16 publications
(9 citation statements)
references
References 22 publications
0
9
0
Order By: Relevance
“…KG-135 is a quality-controlled standardized formulation enriched with the red ginseng-specific antitumorigenic ginsenosides such as Rk1, Rg3, and Rg5 [11]. It had been shown to induce marked G1 cell cycle arrest in prostate and cervical cancer cells.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…KG-135 is a quality-controlled standardized formulation enriched with the red ginseng-specific antitumorigenic ginsenosides such as Rk1, Rg3, and Rg5 [11]. It had been shown to induce marked G1 cell cycle arrest in prostate and cervical cancer cells.…”
Section: Discussionmentioning
confidence: 99%
“…The quality-controlled standardized ginsenoside formulation KG-135 was prepared as described previously [11] and supplied from the Ginseng Science Inc. (Seoul, Korea). It was dissolved in dimethylsulfoxide (Sigma, St. Louis, MO, USA) and diluted in sterile culture medium immediately prior to use.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…In another study, KG-135 diminished the proliferative ability of human prostate cancer (DU-145 and PC3) cells and reduced the growth of PC3 cell tumor xenografts in nude mice by inducing cell cycle arrest through the downregulation of cyclin D1 and Cdk expression (101). Moreover, KG-135 has been shown to enhance etoposide-induced apoptosis in HeLa cells by activating p53 and inducing the expression of Bax and p21 (102). These findings indicate that there is ample scope to develop novel ginsenoside formulations by mixing different types of ginsenosides.…”
Section: Future Perspectivesmentioning
confidence: 96%
“…Up-to-now the most promising of these compounds is combretastatin A-4 (cis-3,4,4',5tetramethoxy-3'-hydroxy stilbene ) which has been shown to cause mitotic arrest in a variety of cancer cell lines, including multi-drug-resistant ones, and has also demonstrated cancer antiangiogenetic properties. [52] Panax ginseng…”
Section: Scutellaria Baicalensismentioning
confidence: 99%